Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Vienna
About this trial
The goal of this observational study is to learn whether hazardous alcohol consumption, measured objectively by carbohydrate-deficient transferrin (CDT) levels at intensive care unit (ICU) admission, is associated with worse outcomes in critically ill patients. The main question it aims to answer is:
Do elevated CDT levels at ICU admission predict increased short-term mortality and adverse clinical outcomes in adult non-traumatic ICU patients? Participants admitted to the intensive care unit via the emergency department will have CDT levels measured as part of the study. Researchers will then collect and analyze clinical data, including mortality, duration of mechanical ventilation, delirium, ICU length of stay, renal replacement therapy, and ICU readmission rates, during hospitalization and follow-up.
Eligibility criteria
Qualifiers
all patients ≥ 18 admitted to the Department of Emergency Medicine and subsequently transferred to an in-house intensive care unit (ICU)
Disqualifiers
Patients transferred to other hospital departments prior to completion of intensive care
Patients admitted directly to the ICU without passing the ED
Patients admitted to intermediate care units
Patients with pre-existing or newly diagnosed hepatic cirrhosis
Trial design
Treatments tested in this trial
- Carbohydrate-Deficient Transferrin (CDT) Measurement
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov